Total Value
$7514.20B
Holdings Count
90
Period of Report
Dec 31, 2024
Report Type
HR
| Issuer | CUSIP | Value | Shares |
|---|---|---|---|
| ASCENDIS PHARMA A/S - ADR | 04351P101 | $1392.22B | 10,112,744 |
| VAXCYTE INC | 92243G108 | $711.30B | 8,689,190 |
| JANUX THERAPEUTICS INC | 47103J105 | $554.98B | 10,365,652 |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | $340.61B | 6,084,412 |
| LEGEND BIOTECH CORP-ADR | 52490G102 | $244.28B | 7,506,934 |
| EDGEWISE THERAPEUTICS INC | 28036F105 | $237.87B | 8,909,091 |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | $227.32B | 8,845,000 |
| WAVE LIFE SCIENCES LTD | Y95308105 | $225.16B | 18,202,009 |
| ARCELLX INC | 03940C100 | $213.76B | 2,787,327 |
| AVIDITY BIOSCIENCES INC | 05370A108 | $183.22B | 6,300,408 |
| SEPTERNA INC | 81734D104 | $160.21B | 6,995,858 |
| DYNE THERAPEUTICS INC | 26818M108 | $150.34B | 6,381,144 |
| TYRA BIOSCIENCES INC | 90240B106 | $147.86B | 10,637,290 |
| RXSIGHT INC | 78349D107 | $128.68B | 3,743,018 |
| BICARA THERAPEUTICS INC | 055477103 | $121.17B | 6,955,993 |
| LENZ THERAPEUTICS INC | 52635N103 | $120.64B | 4,178,823 |
| ARS PHARMACEUTICALS INC | 82835W108 | $114.58B | 10,860,977 |
| 89BIO INC | 282559103 | $110.85B | 14,175,398 |
| SPDR S&P BIOTECH ETF | 78464A870 | $110.62B | 1,228,240 |
| GERON CORP | 374163103 | $106.23B | 30,009,536 |
| ARTIVA BIOTHERAPEUTICS INC | 04317A107 | $99.32B | 9,853,302 |
| AXSOME THERAPEUTICS INC | 05464T104 | $84.61B | 1,000,000 |
| VERONA PHARMA PLC - ADR | 925050106 | $82.05B | 1,766,830 |
| DAY ONE BIOPHARMACEUTICALS I | 23954D109 | $72.92B | 5,755,577 |
| APOGEE THERAPEUTICS INC | 03770N101 | $71.10B | 1,569,491 |
| MINERALYS THERAPEUTICS INC | 603170101 | $59.72B | 4,850,984 |
| PRAXIS PRECISION MEDICINES I | 74006W207 | $58.64B | 761,955 |
| RECURSION PHARMACEUTICALS-A | 75629V104 | $52.22B | 7,725,096 |
| CLIMB BIO INC | 28658R106 | $52.09B | 28,939,395 |
| TOURMALINE BIO INC | 89157D105 | $51.49B | 2,538,925 |
| ACRIVON THERAPEUTICS INC | 004890109 | $50.21B | 8,340,508 |
| FULCRUM THERAPEUTICS INC | 359616109 | $48.08B | 10,229,099 |
| 10X GENOMICS INC-CLASS A | 88025U109 | $47.09B | 3,279,401 |
| GH RESEARCH PLC | G3855L106 | $46.81B | 6,686,689 |
| ASTRIA THERAPEUTICS INC | 04635X102 | $45.64B | 5,105,213 |
| VOR BIOPHARMA INC | 929033108 | $44.01B | 39,646,039 |
| STRUCTURE THERAPEUTICS INC | 86366E106 | $41.15B | 1,517,418 |
| DIANTHUS THERAPEUTICS INC | 252828108 | $40.69B | 1,866,400 |
| PEPGEN INC | 713317105 | $40.51B | 10,689,545 |
| EVOLENT HEALTH INC - A | 30050B101 | $40.24B | 3,577,197 |
| KURA ONCOLOGY INC | 50127T109 | $38.77B | 4,451,041 |
| IDEAYA BIOSCIENCES INC | 45166A102 | $34.62B | 1,347,252 |
| ZAI LAB LTD-ADR | 98887Q104 | $33.92B | 1,295,040 |
| CHIMERIX INC | 16934W106 | $30.62B | 8,800,000 |
| CIDARA THERAPEUTICS INC | 171757206 | $29.37B | 1,092,796 |
| MBX BIOSCIENCES INC | 55287L101 | $27.85B | 1,511,334 |
| NKARTA INC | 65487U108 | $26.90B | 10,805,129 |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | $25.68B | 14,932,063 |
| 4D MOLECULAR THERAPEUTICS IN | 35104E100 | $25.42B | 4,563,211 |
| NURIX THERAPEUTICS INC | 67080M103 | $25.12B | 1,333,333 |
| SERA PROGNOSTICS INC-A | 81749D107 | $24.69B | 3,032,808 |
| AEROVATE THERAPEUTICS INC | 008064107 | $24.36B | 9,192,092 |
| EYEPOINT PHARMACEUTICALS INC | 30233G209 | $23.70B | 3,181,818 |
| LARIMAR THERAPEUTICS INC | 517125100 | $23.40B | 6,045,351 |
| CERIBELL INC | 15678C102 | $21.34B | 824,582 |
| TRAVERE THERAPEUTICS INC | 89422G107 | $20.03B | 1,150,000 |
| ENLIVEN THERAPEUTICS INC | 29337E102 | $19.10B | 848,986 |
| TAYSHA GENE THERAPIES INC | 877619106 | $18.81B | 10,872,503 |
| ALECTOR INC | 014442107 | $18.32B | 9,695,228 |
| PROTARA THERAPEUTIC INC | 74365U107 | $17.95B | 3,400,000 |
| C4 THERAPEUTICS INC | 12529R107 | $17.56B | 4,878,000 |
| SOLID BIOSCIENCES INC | 83422E204 | $17.32B | 4,330,446 |
| PLIANT THERAPEUTICS INC | 729139105 | $16.87B | 1,281,000 |
| Bright Minds Biosciences Inc | 10919W405 | $16.60B | 460,829 |
| ITEOS THERAPEUTICS INC | 46565G104 | $16.07B | 2,092,259 |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | $15.31B | 1,093,477 |
| ELEDON PHARMACEUTICALS INC | 28617K101 | $14.69B | 3,566,338 |
| INSMED INC | 457669307 | $13.81B | 200,000 |
| XENCOR INC | 98401F105 | $13.21B | 575,000 |
| IMMATICS NV | N44445109 | $12.44B | 1,750,000 |
| ACLARIS THERAPEUTICS INC | 00461U105 | $11.57B | 4,666,667 |
| MONOPAR THERAPEUTICS INC | 61023L207 | $11.25B | 511,207 |
| THIRD HARMONIC BIO INC | 88427A107 | $9.88B | 960,620 |
| WEREWOLF THERAPEUTICS INC | 95075A107 | $9.09B | 6,144,881 |
| ARVINAS INC | 04335A105 | $8.08B | 421,348 |
| ZURA BIO LTD | G9TY5A101 | $8.04B | 3,217,503 |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | $7.63B | 750,000 |
| BIOAGE LABS INC | 09077V100 | $7.59B | 1,310,589 |
| ADICET BIO INC | 007002108 | $7.25B | 7,541,000 |
| AVALO THERAPEUTICS INC | 05338F306 | $7.18B | 967,000 |
| BOUNDLESS BIO INC | 10170A100 | $6.32B | 2,180,631 |
| ENANTA PHARMACEUTICALS INC | 29251M106 | $5.97B | 1,038,000 |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | $4.75B | 333,333 |
| CLIMB BIO INC | 28658R106 | $4.46B | 2,479,872 |
| SURROZEN INC | 86889P208 | $4.06B | 282,580 |
| LEXEO THERAPEUTICS INC | 52886X107 | $3.60B | 546,554 |
| ALLAKOS INC | 01671P100 | $1.37B | 1,129,931 |
| SCHOLAR ROCK HOLDING CORP | 80706P103 | $761.4M | 17,616 |
| REGULUS THERAPEUTICS INC | 75915K309 | $532.2M | 336,843 |
| SCILEX HOLDING CO | 80880W106 | $441.8M | 1,036,218 |